| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | YMAB | Common Stock | Purchase | $343,019 | +62,516 | +1.5% | $5.49 | 4,342,721 | 27 Nov 2023 | By WG Biotech ApS | F1, F3 |
| transaction | YMAB | Common Stock | Purchase | $178,275 | +30,671 | +0.71% | $5.81 | 4,373,392 | 28 Nov 2023 | By WG Biotech ApS | F2, F3 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $5.38 to $5.60. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | This transaction was executed in multiple trades at prices ranging from $5.51 to $6.00. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares. |